Lionco Pharmaceutical Group Inc. logo

Lionco Pharmaceutical Group Inc. (603669)

Market Closed
11 Aug, 06:57
SSE SSE
¥
6. 18
+0.04
+0.6515%
¥
3.57B Market Cap
- P/E Ratio
0.4% Div Yield
21.59M Volume
- Eps
¥ 6.14
Previous Close
Add Transaction
Day Range
6.06 6.31
Year Range
4.01 8.4
Want to track 603669 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

603669 closed today higher at ¥6.18, an increase of 0.6515% from yesterday's close, completing a monthly increase of 9.7691% or ¥0.55. Over the past 12 months, 603669 stock gained 34.3478%.
603669 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Lionco Pharmaceutical Group Inc. has completed 3 stock splits, with the recent split occurring on May 26, 2020.
The company's stock is traded on one exchange.

603669 Chart

People also search for

Shanghai Haoyuan Chemexpress Co., Ltd.
¥ 95
-2.7934%
Changchun BCHT Biotechnology Co., Ltd.
¥ 15.91
-0.5003%
Zhejiang Taihua New Material Co., Ltd.
¥ 8.45
+0.1185%
Ningbo Fujia Industrial Co., Ltd.
¥ 14.49
+0.9053%
Xiamen King Long Motor Group Co., Ltd.
¥ 12.16
+0.33%

Lionco Pharmaceutical Group Inc. (603669) FAQ

What is the stock price today?

The current price is ¥6.18.

On which exchange is it traded?

Lionco Pharmaceutical Group Inc. is listed on SSE.

What is its stock symbol?

The ticker symbol is 603669.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.4%.

What is its market cap?

As of today, the market cap is 3.57B.

Has Lionco Pharmaceutical Group Inc. ever had a stock split?

Lionco Pharmaceutical Group Inc. had 3 splits and the recent split was on May 26, 2020.

Lionco Pharmaceutical Group Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Ling Ping Tao CEO
SSE Exchange
CNE1000022R8 ISIN
CN Country
475 Employees
5 Jul 2022 Last Dividend
10 May 2018 Last Split
- IPO Date

Overview

Lionco Pharmaceutical Group Co., Ltd. is a prominent entity in the pharmaceutical industry within China, focusing on the research, development, production, and commercialization of a wide range of pharmaceutical products. Since its inception in 2003, the company has committed itself to addressing various healthcare needs through its diverse product portfolio. With its headquarters located in Shannan, China, Lionco Pharmaceutical Group has successfully established itself as a key player in the pharmaceutical sector, leveraging its extensive network of subsidiaries to enhance its market presence and deliver innovative healthcare solutions across the nation.

Products and Services

  • Nutrition: The company offers nutritional supplements and products aimed at improving the overall health and wellbeing of individuals. These products are designed to address nutritional deficiencies and support a balanced diet.
  • Antimicrobial: Lionco Pharmaceutical Group produces antimicrobial agents that are used to inhibit the growth of or kill microorganisms, playing a crucial role in the treatment and prevention of infections.
  • Antiviral: The company's antiviral products are developed to combat viral infections, enhancing the body's ability to fight off viruses and prevent the spread of viral diseases.
  • Digestion: Focused on improving digestive health, these products include enzymes, probiotics, and other formulations designed to aid digestion and promote a healthy gastrointestinal tract.
  • Cardiovascular: Lionco Pharmaceutical Group offers a range of products aimed at supporting cardiovascular health, including treatments for hypertension, heart disease, and other related conditions.
  • Detoxification: The company provides products that assist in the detoxification process, helping to remove toxins from the body and support liver health.
  • Anti-tumor: Focused on oncology, Lionco Pharmaceutical Group develops products designed to treat various types of tumors and support patients undergoing cancer treatment.
  • Other Products: Beyond the specified categories, the company offers a variety of other pharmaceutical products aimed at addressing different health issues and enhancing the quality of life for patients.

Contact Information

Address: Commercial and Residential Building 2, Shannan, China, 856000
Phone: 86 89 8783 0666